Scipher Medicine
Contact
Search
Platform
Solutions
Company
Latest
Careers
Contact
Join Us
All articles
All articles
Press Releases
Publications
News Articles
Media Kit
Show all
Press Releases
Publications
News Articles
Media Kit
1/6/22
Press releases
Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference
12/30/21
Publications
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis
12/16/21
Press releases
Scipher Medicine Appoints Richard Blackburn to its Advisory Board
12/6/21
Press releases
Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA Blood Test Since Its Launch A Year Ago
12/2/21
Press releases
Scipher Medicine Appoints Dr. Michael Elliott to its Science Advisory Board
12/1/21
Publications
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
11/30/21
Press releases
,
News articles
America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
11/16/21
Press releases
Scipher Medicine® Appoints Sam Asgarian, M.D., MBA, Chief Medical Officer
11/15/21
News articles
RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care
11/11/21
News articles
Scipher Medicine
®
to Present at the Jeffries London Healthcare Conference
11/10/21
Publications
A molecular signature response classifier to predict inadequate response to tumor necrosis factor-α Inhibitors: the NETWORK-004 Prospective Observational Study
11/10/21
News articles
Scipher Medicine
®
to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
11/8/21
Publications
Discontinuation of TNFi treatment among Rheumatoid Arthritis patients with a molecular signature of non-response to tumor necrosis factor-ɑ inhibitor therapies
11/8/21
Publications
A molecular signature response classifier predicts the likelihood of non-response to TNF inhibitor therapies in RA at 3 months
11/4/21
Press releases
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
Posts navigation
Previous
1
2
3
…
8
Next